RespireRx Pharmaceuticals Inc (RSPI): Speaking of ampakines, gfp, do you think...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	14
Posts	2972
Boards Moderated	0
Alias Born	07/19/2006

haysaw

Re: gfp927z post# 2948

Thursday, 01/04/2007 11:30:48 PM

Thursday, January 04, 2007 11:30:48 PM

Speaking of ampakines, gfp, do you think that Organon has information gathered on their Org-24448 study? If it is highly likely, that could be a big negative for Cortex/ampakine. Because they are out of favor with the asenapine news, any positive would help. Hell, any positive would help anyway. It would make sense, anyway, for Akzo to "dress-up" the IPO/sale of Organon.

On the other hand, for obvious reasons, no news would be described as "bad news." It probably is not material to Organon (ampakine drug findings), so they would not be required to release info.

Just speculating. Your thoughts?
Curtis

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM